phenylethyl alcohol has been researched along with Non-alcoholic Fatty Liver Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alisi, A; Bianchi, M; Braghini, MR; Comparcola, D; Condorelli, AG; Conti, LA; Crudele, A; De Stefanis, C; Gurrado, F; Lioci, G; Mosca, A; Nobili, R; Panera, N; Sartorelli, MR; Scoppola, V; Smeriglio, A; Svegliati-Baroni, G; Trombetta, D | 1 |
| Álvarez, D; Bustamante, A; Echeverría, F; Espinosa, A; Gonzalez-Mañan, D; Illesca, P; Ortiz, M; Valenzuela, R; Videla, LA | 1 |
| Campos, C; Espinosa, A; Illesca, P; López-Arana, S; Orellana, P; Ortiz, M; Rincón, MA; Soto-Alarcón, SA; Valenzuela, R; Videla, LA | 1 |
| Giannitelli, SM; Gori, M; Merendino, N; Mozetic, P; Rainer, A; Trombetta, M; Zancla, A | 1 |
| Alisi, A; Alterio, A; Braghini, MR; Comparcola, D; Crudele, A; Mosca, A; Panera, N; Raponi, M; Sartorelli, MR; Smeriglio, A; Tozzi, G; Trombetta, D | 1 |
| Abbruzzese, F; Giannitelli, SM; Gigli, G; Gori, M; Mauri, E; Merendino, N; Mozetic, P; Rainer, A; Rossi, F; Trombetta, M; Zancla, A | 1 |
| Echeverría, F; Espinosa, A; Hernandez-Rodas, MC; Illesca, P; Ortiz, M; Rincón-Cervera, MÁ; Valenzuela, A; Valenzuela, R; Videla, LA | 2 |
| Soto-Alarcon, SA; Valenzuela, A; Valenzuela, R; Videla, LA | 1 |
| Hong, MJ; Hur, HJ; Kim, MS; Kim, SH; Kwon, DY; Park, HS | 1 |
| Liu, Y; Ma, Y; Wang, N; Wen, D | 1 |
| Álvarez, D; Bustamante, A; Corbari, A; Echeverría, F; Muñoz, P; Ortiz, M; Soto-Alarcon, SA; Valenzuela, R; Videla, LA | 1 |
| Alisi, A; Crudele, A; Denaro, M; Mosca, A; Nobili, V; Smeriglio, A; Trombetta, D; Zaffina, S | 1 |
| Bastida, S; Benedí, J; Garcimartín, A; López-Oliva, ME; Merino, P; Sánchez-Muniz, FJ; Santos-López, JA | 1 |
| Calignano, A; Canani, RB; Di Guida, F; Lama, A; Magliocca, S; Meli, R; Mollica, MP; Paciello, O; Pagano, TB; Pirozzi, C; Raso, GM; Russo, R; Simeoli, R | 1 |
1 review(s) available for phenylethyl alcohol and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Liver Protective Effects of Extra Virgin Olive Oil: Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved in Protection.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Autophagy; Dietary Fats, Unsaturated; Dietary Supplements; Endoplasmic Reticulum Stress; Food Quality; Functional Food; Humans; Lipogenesis; Liver; Non-alcoholic Fatty Liver Disease; Olive Oil; Phenylethyl Alcohol; Signal Transduction | 2018 |
2 trial(s) available for phenylethyl alcohol and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
Topics: Antioxidants; Biomarkers; Child; Drug Combinations; Female; Humans; Interleukin-10; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenylethyl Alcohol; Vitamin E | 2021 |
The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?
Topics: Administration, Oral; Adolescent; Child; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenylethyl Alcohol; Protein Carbonylation; Treatment Outcome; Vitamin E | 2019 |
12 other study(ies) available for phenylethyl alcohol and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
Topics: Animals; Carbon Tetrachloride; Fibrosis; Liver; Liver Cirrhosis; Mice; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Transcription Factors; Transforming Growth Factor beta; Vitamin E | 2022 |
High-fat diet induces mouse liver steatosis with a concomitant decline in energy metabolism: attenuation by eicosapentaenoic acid (EPA) or hydroxytyrosol (HT) supplementation and the additive effects upon EPA and HT co-administration.
Topics: Adenosine Triphosphate; Animals; Diet, High-Fat; Dietary Supplements; Drug Synergism; Eicosapentaenoic Acid; Energy Metabolism; Fatty Acids, Omega-3; Humans; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol | 2019 |
Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration.
Topics: Animals; Diet, High-Fat; Docosahexaenoic Acids; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Phenylethyl Alcohol; Random Allocation | 2020 |
Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD-on-a-chip study.
Topics: Hep G2 Cells; Humans; Lab-On-A-Chip Devices; Liver; Models, Biological; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Quercetin | 2021 |
Nano-encapsulation of hydroxytyrosol into formulated nanogels improves therapeutic effects against hepatic steatosis: An in vitro study.
Topics: Humans; Nanogels; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenylethyl Alcohol | 2021 |
Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
Topics: Animals; Antioxidants; Diet, High-Fat; Down-Regulation; Liver; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; PPAR alpha | 2017 |
Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
Topics: Animals; Antioxidants; Biomarkers; Delta-5 Fatty Acid Desaturase; Diet, High-Fat; Dietary Supplements; Fatty Acid Desaturases; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Hydroxylation; Insulin Resistance; Linoleoyl-CoA Desaturase; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organ Specificity; Oxidative Stress; Phenylethyl Alcohol; Random Allocation; Weaning | 2017 |
Caffeic Acid Phenethyl Ester Improves Metabolic Syndrome by Activating PPAR-γ and Inducing Adipose Tissue Remodeling in Diet-Induced Obese Mice.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeic Acids; Diet, High-Fat; Hyperlipidemias; Insulin Resistance; Male; Metabolic Syndrome; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Panniculitis; Phenylethyl Alcohol; PPAR gamma | 2018 |
Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Endoplasmic Reticulum Stress; Gene Expression Regulation; Glucose; Insulin Resistance; Lipid Metabolism; Male; MAP Kinase Signaling System; Mice, Inbred ICR; Non-alcoholic Fatty Liver Disease; Obesity; Panniculitis; Phenylethyl Alcohol | 2018 |
Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT.
Topics: Animals; Antioxidants; Diet, High-Fat; Eicosapentaenoic Acid; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenylethyl Alcohol; Rats | 2018 |
Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.
Topics: Aging; Animal Feed; Animals; Antioxidants; Body Weight; Catalase; Cholesterol, Dietary; Cholic Acid; Colloids; Dietary Fats; Drug Evaluation, Preclinical; Fatty Acids; Glutathione; Hypolipidemic Agents; Liver; Male; Meat; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Phenylethyl Alcohol; Rats; Rats, Wistar; Silicon Dioxide; Superoxide Dismutase; Sus scrofa; Swine | 2016 |
Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD.
Topics: Animals; Disease Models, Animal; Duodenum; Hepatitis; Male; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Rats | 2016 |